Trophoblastic neoplasm

disease
On this page

Also known as neoplasm of trophoblasttrophoblast neoplasmtrophoblast neoplasm (disease)trophoblast tumortrophoblast tumourtrophoblastic neoplasm (morphologic abnormality)trophoblastic neoplasm NOS (morphologic abnormality)trophoblastic neoplasmstrophoblastic tumortrophoblastic tumor (qualifier value)trophoblastic tumourtrophoblastic tumour (qualifier value)tumor of trophoblasttumour of trophoblast

Summary

Trophoblastic neoplasm (MONDO:0002872) is a cancer and 5 clinical trials. Top therapeutic interventions include pemetrexed. A subtype of neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer
  • Clinical trials: 5

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nametrophoblastic neoplasm
Mondo IDMONDO:0002872
MeSHD014328
DOIDDOID:4085
NCITC3422
UMLSC0041182
MedGen21708
Anatomy (UBERON)UBERON:0000088
Is cancer (heuristic)yes

Also known as: neoplasm of trophoblast · trophoblast neoplasm · trophoblast neoplasm (disease) · trophoblast tumor · trophoblast tumour · trophoblastic neoplasm · trophoblastic neoplasm (morphologic abnormality) · trophoblastic neoplasm NOS (morphologic abnormality) · trophoblastic neoplasms · trophoblastic tumor · trophoblastic tumor (qualifier value) · trophoblastic tumour · trophoblastic tumour (qualifier value) · tumor of trophoblast · tumour of trophoblast

Disease family

This is a subtype of neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumorneoplastic disease or syndromeneoplasmtrophoblastic neoplasm

Related subtypes (47): pre-malignant neoplasm, endocrine gland neoplasm, giant cell tumor, hematopoietic and lymphoid system neoplasm, skin neoplasm, mesenchymal cell neoplasm, epidural spinal canal neoplasm, skeletal muscle neoplasm, cancer, germ cell tumor, benign neoplasm, upper aerodigestive tract neoplasm, histiocytoma, embryonal neoplasm, head and neck neoplasm, epithelial neoplasm, reproductive system neoplasm, non-seminomatous lesion, odontogenic cyst, phosphaturic mesenchymal tumor, thyroglossal duct cyst, hamartoma, mesenchymoma, mesothelial neoplasm, peritoneal neoplasm, virus associated tumor, nail tumor, respiratory tract neoplasm, spindle cell neoplasm, mixed neoplasm, urinary system neoplasm, cystic neoplasm, childhood neoplasm, melanocytic neoplasm, digestive system neoplasm, nervous system neoplasm, neoplasm of thorax, connective tissue neoplasm, bronchial adenomas/carcinoids childhood, diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, erythroplakia, retroperitoneal neoplasm, cardiovascular neoplasm, dermoid or epidermoid cyst of the central nervous system, connective and soft tissue neoplasm, NTRK fusion positive cancer, RET fusion positive cancer

Subtypes (4): testicular trophoblastic tumor, choriocarcinoma, hydatidiform mole, gestational trophoblastic neoplasm

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 5.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified3
PHASE22

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06638931PHASE2RECRUITINGAgnostic Therapy in Rare Solid Tumors
NCT00190918PHASE2COMPLETEDA Trial for Patients With Gestational Trophoblastic Disease
NCT00166790Not specifiedUNKNOWNDetection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease
NCT00294177Not specifiedUNKNOWNConformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma
NCT03488901Not specifiedUNKNOWNChemoresistance of Trophoblastic Tumors

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
PEMETREXED41